SELLAS Life Sciences Group, Inc. (SLS) vs Vera Therapeutics, Inc. (VERA)

SELLAS Life Sciences Group, Inc. and Vera Therapeutics, Inc. are both Biotechnology companies. SELLAS Life Sciences Group, Inc. and Vera Therapeutics, Inc. are of similar size ($2.4B and $2.4B). Across the 9 metrics below, SELLAS Life Sciences Group, Inc. leads on 7 and Vera Therapeutics, Inc. on 2.

Valuation

Metric SLS VERA Biotechnology median
P/E n/m n/m 7.88
P/S 209.18 n/m 11.47
P/B 15.96 5.76 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 196.06 n/m 10.73
Earnings yield (1.81%) (17.92%) (28.84%)
Free cash flow yield (1.75%) (14.43%) (23.03%)

Profitability

Metric SLS VERA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (39.63%) (91.75%) (57.72%)
Return on assets (36.54%) (72.32%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SLS VERA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 50.00% (69.45%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SLS VERA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 18.83 10.92 4.73
Net debt to EBITDA 2.54 2.00 0.96

Dividend

Metric SLS VERA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric SLS VERA Biotechnology median
Market cap 2.37b 2.40b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack